Management of Resistant Hypertension

Current Medication Assessment

• The patient is currently on hydrochlorothiazide 12.5 mg daily, losartan 100 mg daily, metoprolol tartrate 50 mg twice daily, and spironolactone 25 mg daily, as part of their antihypertensive regimen 1

Next Step in Management Algorithm

• Adding a dihydropyridine calcium channel blocker (such as amlodipine 5-10 mg daily) is the most appropriate next step for this patient with resistant hypertension, as recommended by the European Heart Journal 1, 3
• The European Society of Cardiology recommends ensuring patient is taking full therapeutic doses of current medications before adding new ones 2

Special Considerations

• The European Heart Journal suggests evaluating for primary aldosteronism, renal artery stenosis, obstructive sleep apnea, and pheochromocytoma in patients with resistant hypertension 1

Monitoring Recommendations

• The American Heart Association recommends rechecking blood pressure within 2-4 weeks after medication adjustment, with a target blood pressure of <130/80 mmHg 1, 3
• The European Heart Journal recommends monitoring for adverse effects, including orthostatic hypotension, especially when adding additional agents 1

Advanced Options

• The European Heart Journal suggests considering referral to a hypertension specialist if blood pressure remains uncontrolled despite optimized multi-drug therapy 3
• Catheter-based renal denervation may be considered if performed at a high-volume center, as recommended by the European Heart Journal 1

Lifestyle Modifications

• The European Heart Journal and the American Heart Association recommend emphasizing the importance of lifestyle modifications, such as sodium restriction, weight loss, and physical activity, even with multiple medications 1, 3